Home » Newsletters » BioWorld

BioWorld

July 8, 1992

View Archived Issues

ANTISENSE DRUG FARING WELL IN SAFETY TRIALS

Ribi To Expand Manufacturing Facility

PPL RAISES $11.6 MILLION IN FINANCING

WAITING PERIOD EXPIRES FOR SCIOS-NOVA MERGER

IMMUNOMEDICS FOUNDER STEPS ASIDE

ELAN STOCK PURCHASE AUTHORIZED

OPPENHEIMER FUNDS INVEST IN PGS

GENE THERAPY FOR CF GETS ORPHAN DESIGNATION

ECOSCIENCE CRADA FOR BIOFUNGICIDE

AMGEN, CELLPRO TEAM FOR CANCER TRIALS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...